Canadian National Railway Company, together with its subsidiaries, engages in the rail, intermodal, trucking, and related transportation businesses in Canada and the United States. The company provides rail services, which include equipment, custom brokerage services, transloading and distribution, business development and real estate, and private car storage services; and intermodal services, such as temperature controlled cargo, port partnerships, transloading and distribution, logistics parks, customs brokerage, and trucking. It offers door-to-door services, import and export dray, and interline services, as well as specialized services, comprising flatbed trucks, on-deck mobile transport trays, expedited cargo, and permit/overweight services; and supply chain services. It serves automotive, coal, fertilizers, temperature controlled cargo, forest products, dimensional, grain, metal and minerals, petroleum and chemicals, consumer goods, and third party logistics applications. Canadian National Railway Company was incorporated in 1919 and is headquartered in Montreal, Canada.

Canadian National Railway Company

An announcement from Centuria Capital Group ( ($AU:CNI) ) is now available. Centuria Capital Group has disclosed an internal reallocation of staple...

Centuria Director Restructures Stapled Securities With No Change in Beneficial Ownership

Analysts have been eager to weigh in on the Industrial Goods sector with new ratings on Copa Holdings (CPA), Canadian National Railway (CNI) and Ke...

Analysts Have Conflicting Sentiments on These Industrial Goods Companies: Copa Holdings (CPA), Canadian National Railway (CNI) and Kennametal (KMT)

Centuria Capital Group ( ($AU:CNI) ) has issued an update. Mitsubishi UFJ Financial Group, Inc. has lodged a notice that it has ceased to be a subs...

Mitsubishi UFJ Exits Substantial Holding in Centuria Capital Fund

Centuria Capital Group ( ($AU:CNI) ) has issued an update. First Sentier Group Limited and a broad network of related entities, including several F...

First Sentier Group exits substantial holding in Centuria Capital Group

In a report released on May 19, from Citic Securities maintained a Buy rating on China International Capital, with a price target of HK$30.00. The ...

Citic Securities Keeps Their Buy Rating on China International Capital (CNICF)

The latest update is out from Scinai Immunotherapeutics ( ($SCNI) ). On May 12, 2026, Scinai Immunotherapeutics filed a report announcing its Annua...

Scinai Immunotherapeutics Sets June 16, 2026 Shareholder Meeting to Expand Share Capital and Approve Executive Incentives

Scinai Immunotherapeutics ( ($SCNI) ) has shared an announcement. On February 17, 2026, Scinai Immunotherapeutics completed the acquisition of Reci...

Scinai Immunotherapeutics Files Pro Forma Financials After February Acquisition of Recipharm Israel

The latest update is out from Canadian National Railway ( ($TSE:CNR) ). At its annual meeting of shareholders held on May 1, 2026, Canadian Nationa...

Canadian National Railway Shareholders Back Board, Pay Plan and Climate Strategy at 2026 AGM

An update from Canadian National Railway ( ($TSE:CNR) ) is now available. Canadian National Railway Company, a leading North American freight rail ...

Canadian National Railway Shareholders Back Board Slate, Re-Elect Bruder as Chair

In a report released today, from Desjardins maintained a Buy rating on Canadian National Railway, with a price target of C$163.00. In addition to D...

Canadian National Railway (CNI) Gets a Buy from Desjardins

BOCOM International Holdings Company analyst maintained a Buy rating on China International Capital yesterday and set a price target of HK$26.00. T...

BOCOM International Holdings Company Keeps Their Buy Rating on China International Capital (CNICF)

An announcement from Canadian National Railway ( ($TSE:CNR) ) is now available. On April 29, 2026, CN announced it had filed a new shelf prospectus...

Canadian National Railway Files New Cross-Border Debt Shelf

Scinai Immunotherapeutics ( ($SCNI) ) just unveiled an announcement. On April 23, 2026, Scinai Immunotherapeutics Ltd. entered into a securities pu...

Current Quarter	$1.39	Next Quarter	$1.46
Current Year	$5.76	Next Year	$6.41
QoQ Growth	+5.0%	YoY Growth	+11.3%
3Y EPS CAGR	+0.5%	Target Price	$118.20
Consensus	Buy	Upside	+1.6%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CNI	$116.39	+1.88%	1.34M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CNI	$116.39	+1.9%	1.34M
3
4
5
6

CNI

CNI

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Canadian National Railway Company Data in Excel

Get Canadian National Railway Company Data in Excel